V F Semiglazov. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal, Humanized/therapeutic useAntineoplastic Agents/therapeutic useAntineoplastic Agents, Hormonal/therapeutic useBiomarkers, Tumor/analysisBreast Neoplasms/chemistryBreast Neoplasms/drug therapyBreast Neoplasms/surgeryBreast Neoplasms/therapyChemotherapy, AdjuvantFemaleGene Expression Regulation, NeoplasticHumansLymph Node Excision/methodsNeoadjuvant Therapy/methodsPostmenopauseReceptor, ErbB-2/antagonists & inhibitorsTrastuzumab
Substances: See more » Antibodies, Monoclonal, HumanizedAntineoplastic AgentsAntineoplastic Agents, HormonalBiomarkers, TumorERBB2 protein, humanReceptor, ErbB-2Trastuzumab
Year: 2013 PMID: 23909027
Source DB: PubMed Journal: Vopr Onkol ISSN: 0507-3758